This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.
Relocation of manufacturing activities for processing human serum raw materials.
| Device | ELECSYS ANTI-HCV TEST SYSTEM |
| Classification Name | Assay, Enzyme Linked Immunosorbent, Hepatitis C Virus |
| Generic Name | Assay, Enzyme Linked Immunosorbent, Hepatitis C Virus |
| Applicant | ROCHE DIAGNOSTICS CORP. |
| Date Received | 2016-01-27 |
| Decision Date | 2016-02-24 |
| PMA | P090008 |
| Supplement | S016 |
| Product Code | MZO |
| Advisory Committee | Microbiology |
| Supplement Type | 30-day Notice |
| Supplement Reason | Process Change - Manufacturer/sterilizer/packager/supplier |
| Expedited Review | No |
| Combination Product | No |
| Applicant Address | ROCHE DIAGNOSTICS CORP. 9115 Hague Rd. indianapolis, IN 46250 |
| Supplement Number | Date | Supplement Type |
|---|---|---|
| P090008 | Original Filing | |
| S023 | 2022-09-30 | Real-time Process |
| S022 | ||
| S021 | 2018-10-26 | Normal 180 Day Track No User Fee |
| S020 | 2018-04-17 | Real-time Process |
| S019 | 2017-10-11 | Real-time Process |
| S018 | 2017-08-03 | 30-day Notice |
| S017 | 2016-02-16 | 30-day Notice |
| S016 | 2016-01-27 | 30-day Notice |
| S015 | 2015-10-07 | 30-day Notice |
| S014 | 2014-08-22 | 30-day Notice |
| S013 | 2014-04-04 | Real-time Process |
| S012 | 2012-11-30 | 30-day Notice |
| S011 | 2012-09-05 | 30-day Notice |
| S010 | ||
| S009 | 2012-02-29 | 30-day Notice |
| S008 | 2012-01-31 | 135 Review Track For 30-day Notice |
| S007 | 2011-11-21 | 30-day Notice |
| S006 | 2011-11-01 | Normal 180 Day Track |
| S005 | 2011-08-29 | 135 Review Track For 30-day Notice |
| S004 | 2011-08-17 | 135 Review Track For 30-day Notice |
| S003 | 2011-05-17 | Normal 180 Day Track No User Fee |
| S002 | 2011-04-11 | 30-day Notice |
| S001 | 2010-07-28 | Normal 180 Day Track |